Crisis management in entrepreneurial biotechnology companies: an explorative case study
by Holger Patzelt, Andreas Zaby, Dodo Zu Knyphausen-Aufsess
International Journal of Biotechnology (IJBT), Vol. 8, No. 3/4, 2006

Abstract: Biotechnology startup companies are often based on little more than a technology with the potential to contribute to the development of innovative products in the future. Failure of this technology leads to a life-threatening crisis for these firms; managers must react quickly to ensure survival of their companies. The existing literature does not provide information on how biotechnology startups successfully escape technology breakdown crises. In this work, we present an in-depth case study of a biopharmaceutical startup company that suffered and successfully escaped a technology breakdown crisis. We illustrate its project acquisition strategy as well as management of financial, organisational, human and social resources after the breakdown. Our findings have implications for managers of entrepreneurial biotechnology firms.

Online publication date: Wed, 15-Mar-2006

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com